|
Community Clinical Oncology Program
|
5U10CA037422-24
|
$4,282,002
|
$42,820
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-35S1
|
$2,923,989
|
$29,240
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-35
|
$10,630,221
|
$106,302
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-22
|
$406,165
|
$4,062
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
2U10CA035192-27A1
|
$569,700
|
$5,697
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Cancer and Leukemia Group B
|
3U10CA031946-30S1
|
$3,449,605
|
$68,992
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-30
|
$10,820,362
|
$216,407
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-27
|
$2,389,751
|
$23,898
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-02
|
$188,304
|
$5,649
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-24
|
$349,765
|
$10,493
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA032291-30
|
$469,660
|
$9,393
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
Dayton Clinical Oncology Program
|
5U10CA035090-29
|
$945,951
|
$9,460
|
Gross, Howard
|
DAYTON CLINICAL ONCOLOGY PROGRAM
|
|
Cancer and Leukemia Group B
|
5U10CA047577-24
|
$95,798
|
$1,916
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
EORTC HEADQUARTERS
|
2U10CA011488-41
|
$232,518
|
$2,325
|
SYLVESTER, RICHARD
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
North Shore CCOP
|
5U10CA035279-28
|
$599,459
|
$5,995
|
VINCIGUERRA, VINCENT
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-28
|
$450,001
|
$4,500
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
|
5U10CA038926-26
|
$4,603,957
|
$138,119
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer and Leukemia Group B
|
5U10CA077597-14
|
$87,915
|
$1,758
|
Liu, Minetta
|
GEORGETOWN UNIVERSITY
|
|
Hematology-Oncology Associates of Central New York CCOP
|
5U10CA045389-25
|
$706,704
|
$7,067
|
KIRSHNER, JEFFREY
|
HEMATOLOGY-ONCOLOGY ASSOCIATES/CTL NY
|
|
Kansas City Clincal Oncology Program CCOP
|
2U10CA035176-27A1
|
$650,000
|
$6,500
|
GAUR, RAKESH
|
KANSAS CITY CLINICAL ONCOLOGY PROGRAM
|
|
LSUHSC-Shreveport Feist-Weiller Cancer Center MBCCOP
|
3U10CA128567-03S2
|
$459,779
|
$9,196
|
MILLS, GLENN
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
|
Southwest Oncology Group
|
5U10CA046282-24
|
$338,795
|
$10,164
|
STIFF, PATRICK
|
LOYOLA UNIVERSITY CHICAGO
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-33
|
$4,682,808
|
$93,656
|
SARGENT, DANIEL
|
MAYO CLINIC
|
|
Heartland Cancer Research CCOP
|
5U10CA114558-07
|
$697,095
|
$6,971
|
LYSS, ALAN
|
MISSOURI BAPTIST MEDICAL CENTER
|
|
Montana Cancer Consortium
|
5U10CA067575-17
|
$440,926
|
$4,409
|
Marchello, Benjamin
|
MONTANA CANCER CONSORTIUM
|
|
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA045564-25
|
$572,575
|
$5,726
|
Schwartz, Michael
|
MOUNT SINAI MEDICAL CENTER (MIAMI BEACH)
|
|
Research Management and Support
|
RMS2011 [E]
|
$335,240,650
|
$39,187
|
N/A
|
National Cancer Institute
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$891,092
|
$89,109
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$152,550
|
$152,550
|
Apolo, Andrea
|
CCR (NCI)
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$300,744
|
$300,744
|
Barchi, Joseph
|
CCR (NCI)
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$87,290
|
$21,822
|
Bates, Susan
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$261,870
|
$52,374
|
Bates, Susan
|
CCR (NCI)
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIA BC 011095
|
$140,304
|
$140,304
|
Bottaro, Donald
|
CCR (NCI)
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIA BC 011123
|
$84,183
|
$42,091
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$336,731
|
$101,019
|
Bottaro, Donald
|
CCR (NCI)
|
|
Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents
|
ZIA BC 006198
|
$713,745
|
$535,308
|
Burke, Terrence
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$904,190
|
$90,418
|
Caporaso, Neil
|
DCEG (NCI)
|
|
CANCER AND INFLAMMATION GENETICS
|
ZIA BC 011300
|
$641,770
|
$192,530
|
Dean, Michael
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$31,501
|
$15,750
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$1,292,566
|
$64,628
|
Edelman, Daniel
|
CCR (NCI)
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$386,737
|
$19,336
|
Feldman, Steven
|
CCR (NCI)
|
|
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
|
ZIA BC 010625
|
$289,264
|
$115,705
|
Fojo, Antonio
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,801,787
|
$480,178
|
Fojo, Antonio
|
CCR (NCI)
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$218,895
|
$43,779
|
Fowler, Daniel
|
CCR (NCI)
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$491,413
|
$49,141
|
Garfield, Susan
|
CCR (NCI)
|
|
Research Nursing
|
ZID BC 010950
|
$3,777,884
|
$188,894
|
Giaccone, Giuseppe
|
CCR (NCI)
|
|
Medical Director's Office
|
ZID BC 010951
|
$1,777,828
|
$17,778
|
Giaccone, Giuseppe
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$548,663
|
$27,433
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$548,663
|
$27,433
|
Gottesman, Michael
|
CCR (NCI)
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,833,772
|
$275,065
|
Gress, Ronald
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $15,293,211
|